Three years from now, Myriad Genetics Inc. believes that its human proteome mapping effort will have produced a set of all possible interactions between all proteins expressed by human cells, plus predicted protein pathways based on the interaction data. The interactions and pathways will not be divided according to tissue, nor will the database contain comparative information on different tissue states. However, MYGN said the proteome database will enable the next level of research, which includes such additional analyses.

MYGN last week announced that with IT and instrumentation support from partners Oracle Corp. and Hitachi Ltd., it can make sense of the terabytes of data the project will generate.